ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Accordingly, screening for metabolites possessing adiponectin-like activities that target AMPK phosphorylation represents a valuable therapeutic approach for the treatment of glucose metabolism disorder in obesity.